Progressive Coronary Dilatation Predicts Worse Outcome in Kawasaki Disease

Wan-Ling Chih1, Pei-Yuan Wu1, Li-Chuang Sun2

  • 1Department of Pediatrics, National Taiwan University Hospital and Medical College, National Taiwan University, Taipei, Taiwan.

The Journal of Pediatrics
|February 8, 2016
PubMed

Insights

Progressive coronary dilatation in Kawasaki disease (KD) patients with large aneurysms indicates worse long-term cardiac outcomes. This finding aids in predicting risks for acute myocardial infarction and ischemia in KD survivors.

Area of Science:

  • Cardiology
  • Pediatric Rheumatology
  • Vascular Biology

Background:

  • Kawasaki disease (KD) can lead to coronary artery aneurysms, posing long-term cardiovascular risks.
  • Large coronary aneurysms (≥ 4 mm) in KD patients require careful monitoring for late sequelae.
  • Serial changes in coronary dimensions are crucial for assessing disease progression and prognosis.

Purpose of the Study:

  • To investigate the impact of serial coronary artery changes on late coronary outcomes in Kawasaki disease patients with significant coronary aneurysms (≥ 4 mm).
  • To identify specific patterns of coronary dilatation that predict adverse cardiovascular events in the long term.

Main Methods:

  • Retrospective review of 78 Kawasaki disease patients with large coronary aneurysms (≥ 4 mm) from 1980-2013.
  • Definition of progressive coronary dilatation based on three consecutive echocardiograms showing vessel enlargement.
  • Analysis of late coronary outcomes, including acute myocardial infarction, cardiovascular death, and ischemia, over a median follow-up of 792 patient-years.

Main Results:

  • Patients with giant aneurysms (≥ 8 mm) had significantly lower 10-year freedom from ischemia (28% vs. 59%) if they exhibited progressive coronary dilatation.
  • Progressive dilatation was associated with a higher probability of aneurysm persistence at 5 years in patients with medium aneurysms (67.2% vs. 14.8%).
  • Neither male sex nor intravenous immunoglobulin therapy correlated with late outcomes in this cohort.

Conclusions:

  • Progressive coronary dilatation, particularly beyond two months post-diagnosis, serves as a significant indicator of prolonged vasculitis and adverse dilative remodeling.
  • These findings suggest that serial echocardiographic monitoring for progressive dilatation is vital for risk stratification in Kawasaki disease patients with large coronary aneurysms.
  • Identifying progressive dilatation aids in predicting worse late coronary outcomes, including ischemia and myocardial infarction.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
414
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
948
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
743
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
842
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
398